Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary – Suven Life Sciences Limited** Suven Life Sciences faces critical compliance risk (10.0/10 score) under SEBI BRSR Core Expansion mandates, with potential enforcement action and delisting exposure if disclosure obligations are not met—a material threat to market access despite the company's modest ₹6.7 crore revenue base. The company's highest financial exposure stems from undefined EPR (Extended Producer Responsibility) applicability (6.5/10 risk), creating contingent liability uncertainty; failure to clarify and implement EPR compliance could trigger regulatory penalties and remediation costs currently unquantified. While GHG and water intensity risks are moderate (5.0/10 each), the absence of reported Scope 1 and 2 emissions data suggests incomplete environmental accounting rather than genuine zero-emission operations—a red flag for hidden compliance gaps. Immediate priority: resolve EPR applicability status and establish baseline emissions inventory to satisfy BRSR P6 disclosure requirements and mitigate regulatory enforcement risk.
Source: Suven Life Sciences Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.